tirzepatide heart failure trial In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with with preserved ejection fraction and obesity. Full results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads Tirzepatide and Cardiovascular Outcomes: A

Although leave-one-out and Baujat analyses were performed, they did not meaningfully reduce heterogeneity, indicating that the variability is intrinsic to the studies themselves

Impact of cognitive-behavioral interventions on weight loss and psychological outcomes: A meta-analysis

Recent Findings Type 2 diabetes treatment with GLP-1RA liraglutide and semaglutide paved way to a ground-breaking therapy specific for obesity, as shown with the SCALE 3 mg/day liraglutide program and the STEP 2.4 mg/week semaglutide program

Links between Metabolic Syndrome and Hypertension: The Relationship with the Current Antidiabetic Drugs

Meeting with your care provider every few months helps catch things early and plan the next steps

Blood in the urine from a UTI may make the urine appear darker and redder in color